Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Tuberculosis

  Free Subscription


13.08.2018

1 AIDS
1 Antimicrob Agents Chemother
1 Eur Respir J
16 Int J Tuberc Lung Dis
2 J Clin Microbiol
1 J Immunol
1 J Infect
1 J Infect Dis
1 Lancet Gastroenterol Hepatol
1 N Engl J Med
4 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AIDS

  1. RHINES AS, Feldman MW, Bendavid E
    Modeling the implementation of population-level isoniazid preventive therapy for tuberculosis control in a high HIV-prevalence setting.
    AIDS. 2018 Aug 8. doi: 10.1097/QAD.0000000000001959.
    PubMed     Text format     Abstract available


    Antimicrob Agents Chemother

  2. KANDLER JL, Mercante AD, Dalton TL, Ezewudo MN, et al
    Validation of novel Mycobacterium tuberculosis isoniazid resistance mutations not detectable by common molecular tests.
    Antimicrob Agents Chemother. 2018 Aug 6. pii: AAC.00974.
    PubMed     Text format     Abstract available


    Eur Respir J

  3. UZORKA JW, Delfos NM, Witte AMC, Scheper H, et al
    Tuberculosis after a borderline QuantiFERON result during screening before infliximab.
    Eur Respir J. 2018;52.
    PubMed     Text format    


    Int J Tuberc Lung Dis

  4. MONK EJM, Kumwenda M, Nliwasa M, Mpunga J, et al
    Factors affecting tuberculosis health message recall 2 years after active case finding in Blantyre, Malawi.
    Int J Tuberc Lung Dis. 2018;22:1007-1015.
    PubMed     Text format     Abstract available

  5. OH CE, Kwon GY, Kwon YH, Lee EJ, et al
    High tuberculosis transmission rate in children with nursery exposure to undetected pulmonary tuberculosis.
    Int J Tuberc Lung Dis. 2018;22:1031-1036.
    PubMed     Text format     Abstract available

  6. SWINDELLS S, Gupta A, Kim S, Hughes MD, et al
    Resource utilization for multidrug-resistant tuberculosis household contact investigations (A5300/I2003).
    Int J Tuberc Lung Dis. 2018;22:1016-1022.
    PubMed     Text format     Abstract available

  7. ZUUR MA, van Asselt ADI, van 't Boveneind-Vrubleuskaya N, Aleksa A, et al
    Cost-utility analysis of high-dose treatment for intermediate-susceptible, dose-dependent tuberculosis patients.
    Int J Tuberc Lung Dis. 2018;22:991-999.
    PubMed     Text format     Abstract available

  8. NHUNG NV, Hoa NB, Anh NT, Anh LTN, et al
    Measuring catastrophic costs due to tuberculosis in Viet Nam.
    Int J Tuberc Lung Dis. 2018;22:983-990.
    PubMed     Text format     Abstract available

  9. DONALD PR, Diacon AH, Lange C, Demers AM, et al
    Droplets, dust and guinea pigs: an historical review of tuberculosis transmission research, 1878-1940.
    Int J Tuberc Lung Dis. 2018;22:972-982.
    PubMed     Text format     Abstract available

  10. SCHWARTZMAN K
    You pay for what you get: the true cost of tuberculosis.
    Int J Tuberc Lung Dis. 2018;22:969.
    PubMed     Text format    

  11. DU PREEZ K, du Plessis L, O'Connell N, Hesseling AC, et al
    Burden, spectrum and outcomes of children with tuberculosis diagnosed at a district-level hospital in South Africa.
    Int J Tuberc Lung Dis. 2018;22:1037-1043.
    PubMed     Text format     Abstract available

  12. HO-FOSTER A, Tenforde MW, Arscott-Mills T, Maramba M, et al
    Risk factors for gastric aspirate culture contamination in children evaluated for tuberculosis in Botswana.
    Int J Tuberc Lung Dis. 2018;22:1044-1050.
    PubMed     Text format     Abstract available

  13. MYO K, Zaw M, Swe TL, Kyaw YY, et al
    Evaluation of Xpert((R)) MTB/RIF assay as a diagnostic test for pulmonary tuberculosis in children in Myanmar.
    Int J Tuberc Lung Dis. 2018;22:1051-1055.
    PubMed     Text format     Abstract available

  14. FOSTER J, McBryde E, Taune M, Peniyamina D, et al
    Cross-border tuberculosis: opportunities, challenges and change.
    Int J Tuberc Lung Dis. 2018;22:1107-1108.
    PubMed     Text format    

  15. BARRETO JN, de Lourdes Monteiro M, da Luz Lima M, Valadas E, et al
    Under-reporting of tuberculosis in Praia, Cape Verde: study reports doubtful results.
    Int J Tuberc Lung Dis. 2018;22:1106.
    PubMed     Text format    

  16. KOESOEMADINATA RC, Kranzer K, Livia R, Susilawati N, et al
    Computer-assisted chest radiography reading for tuberculosis screening in people living with diabetes mellitus.
    Int J Tuberc Lung Dis. 2018;22:1088-1094.
    PubMed     Text format     Abstract available

  17. RAGHUVANSHI S, Kotwal A, Maheshwari R, Sindhwani G, et al
    Evaluation of line-probe assay for molecular analysis and drug susceptibility of extra-pulmonary tuberculosis.
    Int J Tuberc Lung Dis. 2018;22:1077-1081.
    PubMed     Text format     Abstract available

  18. GASPAR PC, Rudolf-Oliveira RCM, Wildner LM, de Moraes ACR, et al
    Evaluation of leucocytes from sputum samples of pulmonary tuberculosis patients using flow cytometry.
    Int J Tuberc Lung Dis. 2018;22:1071-1076.
    PubMed     Text format     Abstract available

  19. TAKENAMI I, de Oliveira CC, Petrilli JD, Machado A, et al
    Serum antiphospholipid antibody levels as biomarkers for diagnosis of pulmonary tuberculosis patients.
    Int J Tuberc Lung Dis. 2018;22:1063-1070.
    PubMed     Text format     Abstract available


    J Clin Microbiol

  20. LOUKIL A, Kirtania P, Bedotto M, Drancourt M, et al
    FISHing Mycobacterium tuberculosis complex using a rpoB DNA probe bait.
    J Clin Microbiol. 2018 Aug 1. pii: JCM.00568-18. doi: 10.1128/JCM.00568.
    PubMed     Text format     Abstract available

  21. FENG JY, Pan SW, Huang SF, Chen YY, et al
    Depressed interferon-gamma responses and treatment outcomes in tuberculosis patients: a prospective cohort study.
    J Clin Microbiol. 2018 Aug 1. pii: JCM.00664-18. doi: 10.1128/JCM.00664.
    PubMed     Text format     Abstract available


    J Immunol

  22. BOHRER AC, Tocheny C, Assmann M, Ganusov VV, et al
    Cutting Edge: IL-1R1 Mediates Host Resistance to Mycobacterium tuberculosis by Trans-Protection of Infected Cells.
    J Immunol. 2018 Aug 1. pii: jimmunol.1800438. doi: 10.4049/jimmunol.1800438.
    PubMed     Text format     Abstract available


    J Infect

  23. BORISOV SE, D'Ambrosio L, Centis R, Tiberi S, et al
    Outcomes of patients with drug-resistant-tuberculosis treated with bedaquiline -containing regimens and undergoing adjunctive surgery.
    J Infect. 2018 Aug 7. pii: S0163-4453(18)30246.
    PubMed     Text format     Abstract available


    J Infect Dis

  24. SHIN SS, Modongo C, Baik Y, Allender C, et al
    Mixed infections are associated with poor treatment outcomes among newly diagnosed tuberculosis patients independent of pre-treatment heteroresistance.
    J Infect Dis. 2018 Aug 4. pii: 5066433. doi: 10.1093.
    PubMed     Text format     Abstract available


    Lancet Gastroenterol Hepatol

  25. THE LANCET GASTROENTEROLOGY HE
    The Global Fund and Heineken.
    Lancet Gastroenterol Hepatol. 2018;3:213.
    PubMed     Text format    


    N Engl J Med

  26. DIALLO T, Adjobimey M, Ruslami R, Trajman A, et al
    Safety and Side Effects of Rifampin versus Isoniazid in Children.
    N Engl J Med. 2018;379:454-463.
    PubMed     Text format     Abstract available


    PLoS One

  27. JOSHI B, Lestari T, Graham SM, Baral SC, et al
    The implementation of Xpert MTB/RIF assay for diagnosis of tuberculosis in Nepal: A mixed-methods analysis.
    PLoS One. 2018;13:e0201731.
    PubMed     Text format     Abstract available

  28. PRIEDEMAN SKILES M, Curtis SL, Angeles G, Mullen S, et al
    Evaluating the impact of social support services on tuberculosis treatment default in Ukraine.
    PLoS One. 2018;13:e0199513.
    PubMed     Text format     Abstract available

  29. KO Y, Lee HY, Park YB, Hong SJ, et al
    Correlation of microbiological yield with radiographic activity on chest computed tomography in cases of suspected pulmonary tuberculosis.
    PLoS One. 2018;13:e0201748.
    PubMed     Text format     Abstract available

  30. NOGUEIRA BMF, Rolla VC, Akrami KM, Kiene SM, et al
    Correction: Factors associated with tuberculosis treatment delay in patients co-infected with HIV in a high prevalence area in Brazil.
    PLoS One. 2018;13:e0202292.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Tuberculosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: